Acasă › Cancer endometrial › California › Los Angeles
Studii clinice pentru Cancer endometrial în Los Angeles, CA
34 studii pentru Cancer endometrial caută participanți în și în jurul orașului Los Angeles (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
În curs de recrutareFaza 3
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
În curs de recrutareFaza 2
- The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
A Study of PHST001 in Advanced Solid Tumors
În curs de recrutareFaza 1
- USC Norris Comprehensive Cancer Center, Los Angeles
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
În curs de recrutareFaza 1/2
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1
- University of California - Los Angeles, Los Angeles
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
În curs de recrutareFaza 1
- Research Site, Los Angeles
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
În curs de recrutareFaza 2
- Cedars-Sinai Medical Center, Los Angeles
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
În curs de recrutareFaza 2
- Research Site, Los Angeles
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
În curs de recrutareFaza 1/2
- California Research Institute (CRI), Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
În curs de recrutareFaza 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- University of Southern California, Los Angeles
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1
- START Los Angeles, Los Angeles
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
În curs de recrutareFaza 1/2
- Children's Hospital Los Angeles, Los Angeles
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
În curs de recrutareFaza 2
- Cedars Sinai Medical Center, Los Angeles
A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
În curs de recrutareFaza 1
- Valkyrie Clinical Trials, Los Angeles
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
În curs de recrutare
- University of California at Los Angeles, Los Angeles
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
În curs de recrutareFaza 1
- START - Los Angeles, Los Angeles
FOG-001 in Locally Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- University of California, Los Angeles (UCLA), Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- The Angeles Clinic and Research Institute, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
În curs de recrutareFaza 1/2
- Los Angeles Cancer Network, Los Angeles
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- UCLA - Hematology/Oncology Clinical Research Unit, Los Angeles
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
În curs de recrutareFaza 1/2
- University of California Los Angeles Medical Center, Los Angeles
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
În curs de recrutareFaza 1
- START Los Angeles, Los Angeles
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
În curs de recrutareFaza 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Ellison Clinic at Saint John's, Los Angeles
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
În curs de recrutareFaza 1
- Cedars-Sinai Medical Center, Los Angeles
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
În curs de recrutareFaza 2
- UCLA, Los Angeles
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
În curs de recrutareFaza 1
- UCLA - JCCC Clinical Research Unit, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
În curs de recrutareFaza 1/2
- University of Southern California, Los Angeles
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
În curs de recrutareFaza 1/2
- University of Southern California, Los Angeles
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
În curs de recrutareFaza 2
- University of Southern California, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Cedars Sinai Medical Center, Los Angeles
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
În curs de recrutareFaza 1/2
- The Angeles Clinic and Research Institute, Los Angeles
Studii pentru Cancer endometrial în alte orașe
- Houston, TX68 studii
- New York City, NY52 studii
- Boston, MA50 studii
- Arlington, VA39 studii
- Nashville, TN38 studii
- St. Louis, MO29 studii
- Philadelphia, PA28 studii
- San Antonio, TX27 studii
- Columbus, OH25 studii
- Oklahoma City, OK25 studii
- Chicago, IL25 studii
- Queens, NY25 studii
Alte studii în Los Angeles
- Cancer pulmonar cu celule non-pătrate87 studii
- Cancer (toate tipurile)74 studii
- Cancer de sân73 studii
- Cancer de prostată61 studii
- Cancer colorectal59 studii
- Cancer metastatic57 studii
- Cancer ovarian50 studii
- Cancer pulmonar45 studii
- Carcinom cu celule scuamoase de cap și gât42 studii
- Cancer pancreatic35 studii
- Melanom34 studii
- Cancer de sân triplu negativ27 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.